Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.24.1.1.u2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Current assets    
Cash and cash equivalents $ 140,670,000 $ 143,991,000
Marketable securities - available-for-sale debt securities (amortized cost of $2,981 and $2,940) net of allowance for expected credit losses of $0 and $0 2,982,000 2,947,000
Accounts receivable, net of allowance for expected credit losses of $0 and $0 8,404,000 821,000
Other current assets and prepaid expenses 34,847,000 59,793,000
Total current assets 186,903,000 207,552,000
Restricted cash 2,858,000 3,026,000
Operating lease right-of-use assets, net of accumulated amortization of $14,381 and $13,220 19,434,000 20,762,000
Property, plant and equipment, net of accumulated depreciation of $48,445 and $46,020 48,291,000 50,946,000
Intangible assets, net of accumulated amortization of $5,198 and $5,155 524,000 330,000
Total assets 258,010,000 282,616,000
Current liabilities    
Accounts payable 6,587,000 8,128,000
Operating lease liabilities, current 5,250,000 5,384,000
Accrued expenses and other current liabilities 23,050,000 30,303,000
Deferred revenue, current 31,524,000 28,973,000
Total current liabilities 66,411,000 72,788,000
Operating lease liabilities, non-current 18,442,000 19,851,000
Deferred revenue, non-current 147,365,000 149,060,000
Other liabilities, non-current 1,417,000 1,404,000
Total liabilities 233,635,000 243,103,000
Stockholders' equity    
Common stock - Ordinary shares par value £0.001, 1,702,760,280 authorized and 1,532,974,878 issued and outstanding (2023: 1,702,760,280 authorized and 1,363,008,102 issued and outstanding) 2,081,000 1,865,000
Additional paid in capital 1,096,690,000 1,064,569,000
Accumulated other comprehensive loss (2,720,000) (3,748,000)
Accumulated deficit (1,071,676,000) (1,023,173,000)
Total stockholders' equity 24,375,000 39,513,000
Total liabilities and stockholders' equity $ 258,010,000 $ 282,616,000